As of Nov 19, 2026, 0 of 1 active firms rate BIOX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BIOX EPS & revenue forecast
EPS · THIS QUARTER
$-0.06
Range $-0.06 – $-0.06 · 1 analysts · -91% YoY
Next period, 1 analysts expect Bioceres Crop Solutions Corp to earn $-0.06 a share (range $-0.06 – $-0.06), versus $-0.70 a year earlier.
REVENUE · THIS QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —)., rising to $0 next year.
Top analysts covering Bioceres Crop Solutions Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BIOX.
#1
Kristen Owen
Oppenheimer · Rank #422
Buy
$6.00+2885.1% to target
Overall win rate
27%
+ Follow
#2
Austin Moeller
Canaccord Genuity · Rank #440
Neutral
$2.00+895.0% to target
Overall win rate
31%
+ Follow
#3
Ben Klieve
Lake Street · Rank #529
Buy
$5.00+2387.6% to target
Overall win rate
26%
+ Follow
#4
BK
Ben Klieve
Benchmark Co.
Buy
$5.00+2387.6% to target
Coverage
—
+ Follow
#5
KD
Kemp Dolliver
Brookline Capital Markets
Neutral
$26.00+12835.3% to target
Coverage
—
+ Follow
BIOX stock forecast FAQ
What is BIOX's average 12-month price target?+
The 1 active firms with a live target average $2.00 for Bioceres Crop Solutions Corp over the next 12 months, ranging from a $2.00 high to a $2.00 low, as of Nov 19, 2026.
Is BIOX stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover BIOX?+
1 active firms have a recognized rating on Bioceres Crop Solutions Corp as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BIOX?+
Among analysts who currently cover BIOX, Kristen Owen of Oppenheimer has the strongest overall Quantellect track record (Rank #422). Their current call is Buy with a $6.00 target.
What is Bioceres Crop Solutions Corp's projected EPS for next quarter?+
The consensus estimate is $-0.06 per share (range $-0.06 – $-0.06) across 1 analysts, rising to — the following year.
How much revenue is Bioceres Crop Solutions Corp expected to report next quarter?+
Consensus revenue is — (range — – —), growing to $0 next year.
Have analysts been upgrading or downgrading BIOX lately?+
As of Nov 19, 2026, 0 of 1 active firms rate BIOX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BIOX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.